These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34055907)

  • 1. Distinctions in the Management, Patient Impact, and Clinical Profiles of Pachyonychia Congenita Subtypes.
    Wu AG; Lipner SR
    Skin Appendage Disord; 2021 Apr; 7(3):194-202. PubMed ID: 34055907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pachyonychia congenita in pediatric patients: natural history, features, and impact.
    Shah S; Boen M; Kenner-Bell B; Schwartz M; Rademaker A; Paller AS
    JAMA Dermatol; 2014 Feb; 150(2):146-53. PubMed ID: 24132595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pachyonychia congenita patients with mutations in KRT6A have more extensive disease compared with patients who have mutations in KRT16.
    Spaunhurst KM; Hogendorf AM; Smith FJ; Lingala B; Schwartz ME; Cywinska-Bernas A; Zeman KJ; Tang JY
    Br J Dermatol; 2012 Apr; 166(4):875-8. PubMed ID: 22098151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The histopathological features of the nail plate in pachyonychia congenita.
    Stewart CL; Takeshita J; Hansen CD; Rubin AI
    J Cutan Pathol; 2020 Apr; 47(4):357-362. PubMed ID: 31845382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revisiting pachyonychia congenita: a case-cohort study of 815 patients.
    Samuelov L; Smith FJD; Hansen CD; Sprecher E
    Br J Dermatol; 2020 Mar; 182(3):738-746. PubMed ID: 31823354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First case of pachyonychia congenita in the Czech Republic.
    Jiráková A; Rajská L; Rob F; Džambová M; Sečníková Z; Göpfertová D; Schwartz M; Smith F; Lotti T; Hercogová J
    Dermatol Ther; 2015; 28(1):10-2. PubMed ID: 25174302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgrediens pachyonychia congenita (PC): case series of a nonclassical PC presentation.
    Harris K; Hull PR; Hansen CD; Smith FJ; McLean WH; Arbiser JL; Leachman SA
    Br J Dermatol; 2012 Jan; 166(1):124-8. PubMed ID: 21790523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pachyonychia Congenita: A Spectrum of KRT6a Mutations in Australian Patients.
    Forrest CE; Casey G; Mordaunt DA; Thompson EM; Gordon L
    Pediatr Dermatol; 2016 May; 33(3):337-42. PubMed ID: 27041546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of clinically useful predictive genetic variants in pachyonychia congenita.
    Samuelov L; Sarig O; Adir N; Pavlovsky M; Smith FJ; Schwartz J; Hansen CD; Sprecher E
    Clin Exp Dermatol; 2021 Jul; 46(5):867-873. PubMed ID: 33486795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phenotypic and molecular genetic features of pachyonychia congenita.
    McLean WH; Hansen CD; Eliason MJ; Smith FJ
    J Invest Dermatol; 2011 May; 131(5):1015-7. PubMed ID: 21430705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pachyonychia Congenita Project: Advancing Research and Drug Development through Collaboration.
    Schwartz JN; Evans HA; O'toole EA; Hansen CD
    Keio J Med; 2023 Dec; ():. PubMed ID: 38072449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and molecular findings of pachyonychia congenita type 2 (PC-2)].
    Cammarata-Scalisi F; Natsuga K; Toyonaga E; Nishie W; Shimizu H; Stock F; Milano M; Petrosino P; Arenas de Sotolongo A; Medina Y
    Gac Med Mex; 2015; 151(2):270-2. PubMed ID: 25946540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of reported cases of pachyonychia congenita tarda.
    Tatiane A; Slape D; Lawless R; Frew JW
    Clin Exp Dermatol; 2019 Aug; 44(6):606-612. PubMed ID: 31074523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pachyonychia congenita: a case report of a successful treatment with rosuvastatin in a patient with a KRT6A mutation.
    Abdollahimajd F; Rajabi F; Shahidi-Dadras M; Saket S; Youssefian L; Vahidnezhad H; Uitto J
    Br J Dermatol; 2019 Sep; 181(3):584-586. PubMed ID: 30307612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pachyonychia congenita type 2, N92S mutation of keratin 17 gene: clinical features, mutation analysis and pathological view.
    Cogulu O; Onay H; Aykut A; Wilson NJ; Smith FJ; Dereli T; Ozkinay F
    Eur J Pediatr; 2009 Oct; 168(10):1269-72. PubMed ID: 19107515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype‒Structurotype‒Phenotype Correlations in Patients with Pachyonychia Congenita.
    Wu TT; Eldirany SA; Bunick CG; Teng JMC
    J Invest Dermatol; 2021 Dec; 141(12):2876-2884.e4. PubMed ID: 34116063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular genetic analysis of the expanding pachyonychia congenita case collection.
    Wilson NJ; O'Toole EA; Milstone LM; Hansen CD; Shepherd AA; Al-Asadi E; Schwartz ME; McLean WH; Sprecher E; Smith FJ
    Br J Dermatol; 2014 Aug; 171(2):343-55. PubMed ID: 24611874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An appraisal of oral retinoids in the treatment of pachyonychia congenita.
    Gruber R; Edlinger M; Kaspar RL; Hansen CD; Leachman S; Milstone LM; Smith FJ; Sidoroff A; Fritsch PO; Schmuth M
    J Am Acad Dermatol; 2012 Jun; 66(6):e193-9. PubMed ID: 21601946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a recurrent mutation in keratin 6a in a patient with overlapping clinical features of pachyonychia congenita types 1 and 2.
    Ward KM; Cook-Bolden FE; Christiano AM; Celebi JT
    Clin Exp Dermatol; 2003 Jul; 28(4):434-6. PubMed ID: 12823309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype-phenotype correlations among pachyonychia congenita patients with K16 mutations.
    Fu T; Leachman SA; Wilson NJ; Smith FJ; Schwartz ME; Tang JY
    J Invest Dermatol; 2011 May; 131(5):1025-8. PubMed ID: 21160496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.